To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis

Exclusion Criteria

• •Participants \<18 years;
• •Prior treatment with anti-interleukin 6 (IL-6) or IL-6 receptor (IL-6R) antagonists;
• •Treatment with tumor necrosis factor (TNF) antagonists;
• •Treatment with RA-directed biologic agents other than with a TNF-α antagonist mechanism as follows: Anakinra, Abatacept, Rituximab or other cell-depleting agent;
• •Prior treatment with a Janus kinase inhibitor.
• •The above information was not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.